REQUEST A DEMO
Total
USD $0.00
Search more companies

Fitoemika Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Fitoemika Sp. z o.o. Profile Updated: May 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Fitoemika Sp. z o.o. is a company in Poland, with a head office in Lublin. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on May 19, 2021. In its most recent financial highlights, the company reported a net sales revenue increase of 580.89% in 2023. Its’ total assets recorded a negative growth of 64.44%.

Headquarters
Ul. Frezerow 3
Lublin; Lubelskie; Postal Code: 20-209

Contact Details: Purchase the Fitoemika Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Fitoemika Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Fitoemika Sp. z o.o. report to view the information.
Incorporation Date:
May 19, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Fitoemika Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
580.89%
Total operating revenue
580.89%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-64.44%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
196.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?